$2.1 Billion is the total value of HealthCor Management, L.P.'s 65 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 121.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HZNP | Sell | HORIZON PHARMA PLC | $103,880,000 | +43.9% | 4,000,000 | -28.6% | 4.96% | +23.2% |
MNKKQ | Sell | MALLINCKRODT PUB LTD CO | $101,320,000 | -22.8% | 800,000 | -39.6% | 4.83% | -33.9% |
GILD | New | GILEAD SCIENCES INCcall | $98,130,000 | – | 1,000,000 | +100.0% | 4.68% | – |
LH | Buy | LABORATORY CORP AMER HLDGS | $85,111,000 | +43.4% | 675,000 | +22.7% | 4.06% | +22.8% |
BIIB | New | BIOGEN INC | $80,521,000 | – | 190,700 | +100.0% | 3.84% | – |
A | Buy | AGILENT TECHNOLOGIES INCcall | $75,829,000 | +2.9% | 1,825,000 | +1.4% | 3.62% | -11.9% |
AET | New | AETNA INC NEW | $74,571,000 | – | 700,000 | +100.0% | 3.56% | – |
BKD | Buy | BROOKDALE SR LIVING INC | $73,632,000 | +262.8% | 1,950,000 | +252.3% | 3.51% | +210.6% |
TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $71,645,000 | +338.7% | 1,150,000 | +304.9% | 3.42% | +275.6% |
PFE | Buy | PFIZER INCcall | $69,580,000 | +346.7% | 2,000,000 | +300.0% | 3.32% | +282.5% |
MYL | New | MYLAN N V | $68,039,000 | – | 1,146,400 | +100.0% | 3.25% | – |
JAZZ | New | JAZZ PHARMACEUTICALS PLC | $56,157,000 | – | 325,000 | +100.0% | 2.68% | – |
TSRO | Sell | TESARO INC | $53,095,000 | +36.0% | 925,000 | -11.9% | 2.53% | +16.4% |
MDVN | Sell | MEDIVATION INC | $48,401,000 | -15.5% | 375,000 | -34.8% | 2.31% | -27.7% |
MYL | New | MYLAN N Vcall | $47,480,000 | – | 800,000 | +100.0% | 2.26% | – |
KND | New | KINDRED HEALTHCARE INC | $46,647,000 | – | 1,960,800 | +100.0% | 2.23% | – |
RAD | New | RITE AID CORP | $45,735,000 | – | 5,262,900 | +100.0% | 2.18% | – |
DHR | Buy | DANAHER CORP DELcall | $44,148,000 | +28.8% | 520,000 | +30.0% | 2.11% | +10.2% |
TEVA | New | TEVA PHARMACEUTICAL INDS LTDcall | $43,610,000 | – | 700,000 | +100.0% | 2.08% | – |
BSX | Sell | BOSTON SCIENTIFIC CORP | $42,364,000 | -7.6% | 2,386,700 | -31.0% | 2.02% | -20.9% |
MRK | New | MERCK & CO INC NEW | $41,328,000 | – | 719,000 | +100.0% | 1.97% | – |
ALR | New | ALERE INC | $39,115,000 | – | 799,900 | +100.0% | 1.87% | – |
WBMD | Sell | WEBMD HEALTH CORP | $37,503,000 | -22.6% | 855,555 | -30.2% | 1.79% | -33.8% |
ILMN | Sell | ILLUMINA INC | $36,033,000 | -44.2% | 194,100 | -44.5% | 1.72% | -52.3% |
EW | New | EDWARDS LIFESCIENCES CORP | $35,615,000 | – | 250,000 | +100.0% | 1.70% | – |
BCR | New | BARD C R INC | $33,470,000 | – | 200,000 | +100.0% | 1.60% | – |
VRTX | New | VERTEX PHARMACEUTICALS INC | $32,442,000 | – | 275,000 | +100.0% | 1.55% | – |
PFE | Sell | PFIZER INC | $32,118,000 | -68.0% | 923,200 | -71.3% | 1.53% | -72.6% |
RLYP | New | RELYPSA INC | $31,561,000 | – | 875,000 | +100.0% | 1.51% | – |
HYH | Sell | HALYARD HEALTH INC | $30,543,000 | -29.4% | 620,800 | -34.7% | 1.46% | -39.5% |
MRK | New | MERCK & CO INC NEWcall | $28,740,000 | – | 500,000 | +100.0% | 1.37% | – |
TSRO | New | TESARO INCput | $28,700,000 | – | 500,000 | +100.0% | 1.37% | – |
PDCO | New | PATTERSON COMPANIES INC | $27,810,000 | – | 570,000 | +100.0% | 1.33% | – |
UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $26,485,000 | -47.1% | 225,000 | -50.0% | 1.26% | -54.7% |
ACAD | New | ACADIA PHARMACEUTICALS INC | $23,628,000 | – | 725,000 | +100.0% | 1.13% | – |
AMRI | Sell | ALBANY MOLECULAR RESH INC | $22,440,000 | -13.9% | 1,275,000 | -20.3% | 1.07% | -26.2% |
A | Buy | AGILENT TECHNOLOGIES INC | $21,814,000 | +122.5% | 525,000 | +119.2% | 1.04% | +90.3% |
KYTH | Buy | KYTHERA BIOPHARMACEUTICALS I | $21,314,000 | +570.9% | 425,000 | +364.0% | 1.02% | +474.6% |
TTPH | New | TETRAPHASE PHARMACEUTICALS I | $17,118,000 | – | 467,200 | +100.0% | 0.82% | – |
ABC | New | AMERISOURCEBERGEN CORPput | $17,051,000 | – | 150,000 | +100.0% | 0.81% | – |
VSAR | Buy | VERSARTIS INC | $16,856,000 | -14.2% | 917,600 | +4.9% | 0.80% | -26.6% |
TKMR | New | TEKMIRA PHARMACEUTICALS CORP | $12,550,000 | – | 718,800 | +100.0% | 0.60% | – |
AERI | New | AERIE PHARMACEUTICALS INC | $10,969,000 | – | 350,000 | +100.0% | 0.52% | – |
THC | New | TENET HEALTHCARE CORPcall | $10,892,000 | – | 220,000 | +100.0% | 0.52% | – |
THC | New | TENET HEALTHCARE CORPput | $10,892,000 | – | 220,000 | +100.0% | 0.52% | – |
IART | New | INTEGRA LIFESCIENCES HLDGS C | $10,789,000 | – | 175,000 | +100.0% | 0.52% | – |
ELGX | New | ENDOLOGIX INC | $9,829,000 | – | 575,800 | +100.0% | 0.47% | – |
TMO | Sell | THERMO FISHER SCIENTIFIC INC | $9,149,000 | -81.7% | 68,100 | -83.0% | 0.44% | -84.4% |
DYAX | New | DYAX CORP | $8,208,000 | – | 489,900 | +100.0% | 0.39% | – |
DSCI | Sell | DERMA SCIENCES INC | $7,569,000 | -11.6% | 893,600 | -2.9% | 0.36% | -24.3% |
GILD | Sell | GILEAD SCIENCES INC | $6,791,000 | -94.2% | 69,200 | -94.5% | 0.32% | -95.1% |
ARAY | New | ACCURAY INC | $6,761,000 | – | 727,000 | +100.0% | 0.32% | – |
AKBA | Sell | AKEBIA THERAPEUTICS INC | $6,605,000 | -32.9% | 594,534 | -29.7% | 0.32% | -42.5% |
Q | New | QUINTILES TRANSNATIO HLDGS I | $6,462,000 | – | 96,496 | +100.0% | 0.31% | – |
ASMB | New | ASSEMBLY BIOSCIENCES INC | $6,289,000 | – | 475,000 | +100.0% | 0.30% | – |
SRPT | New | SAREPTA THERAPEUTICS INC | $6,145,000 | – | 462,700 | +100.0% | 0.29% | – |
DGX | New | QUEST DIAGNOSTICS INCput | $5,764,000 | – | 75,000 | +100.0% | 0.28% | – |
DHR | Buy | DANAHER CORP DEL | $5,527,000 | +22.8% | 65,100 | +24.0% | 0.26% | +5.2% |
UNH | New | UNITEDHEALTH GROUP INC | $4,885,000 | – | 41,300 | +100.0% | 0.23% | – |
CVS | New | CVS HEALTH CORP | $4,438,000 | – | 43,000 | +100.0% | 0.21% | – |
IDRA | Buy | IDERA PHARMACEUTICALS INC | $4,325,000 | +21.3% | 1,165,786 | +44.2% | 0.21% | +3.5% |
CI | New | CIGNA CORPORATION | $4,292,000 | – | 33,159 | +100.0% | 0.20% | – |
ELOS | SYNERON MEDICAL LTD | $3,261,000 | +32.7% | 263,400 | 0.0% | 0.16% | +13.9% | |
OPHT | New | OPHTHOTECH CORP | $1,596,000 | – | 34,300 | +100.0% | 0.08% | – |
LENS | New | PRESBIA PLC | $420,000 | – | 56,869 | +100.0% | 0.02% | – |
CEMP | Exit | CEMPRA INC | $0 | – | -11,408 | -100.0% | -0.02% | – |
BLCM | Exit | BELLICUM PHARMACEUTICALS INC | $0 | – | -40,586 | -100.0% | -0.05% | – |
ACHN | Exit | ACHILLION PHARMACEUTICALS INcall | $0 | – | -100,000 | -100.0% | -0.07% | – |
XOMA | Exit | XOMA CORP DEL | $0 | – | -450,000 | -100.0% | -0.09% | – |
KERX | Exit | KERYX BIOPHARMACEUTICALS INC | $0 | – | -178,300 | -100.0% | -0.14% | – |
CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -163,600 | -100.0% | -0.17% | – |
INFI | Exit | INFINITY PHARMACEUTICALS INC | $0 | – | -223,712 | -100.0% | -0.21% | – |
NVAX | Exit | NOVAVAX INC | $0 | – | -649,781 | -100.0% | -0.22% | – |
VAR | Exit | VARIAN MED SYS INCput | $0 | – | -100,000 | -100.0% | -0.48% | – |
PCRX | Exit | PACIRA PHARMACEUTICALS INC | $0 | – | -125,000 | -100.0% | -0.62% | – |
CELG | Exit | CELGENE CORP | $0 | – | -181,600 | -100.0% | -1.13% | – |
ZTS | Exit | ZOETIS INCcl a | $0 | – | -512,500 | -100.0% | -1.23% | – |
ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -127,100 | -100.0% | -1.31% | – |
ZBH | Exit | ZIMMER HLDGS INC | $0 | – | -264,400 | -100.0% | -1.67% | – |
CAH | Exit | CARDINAL HEALTH INC | $0 | – | -385,200 | -100.0% | -1.73% | – |
XLV | Exit | SELECT SECTOR SPDR TRput | $0 | – | -500,000 | -100.0% | -1.91% | – |
NUVA | Exit | NUVASIVE INC | $0 | – | -750,000 | -100.0% | -1.97% | – |
MCK | Exit | MCKESSON CORP | $0 | – | -175,600 | -100.0% | -2.03% | – |
MYL | Exit | MYLAN INC | $0 | – | -698,800 | -100.0% | -2.20% | – |
ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -76,600 | -100.0% | -2.26% | – |
ZBH | Exit | ZIMMER HLDGS INCcall | $0 | – | -400,000 | -100.0% | -2.53% | – |
OCR | Exit | OMNICARE INC | $0 | – | -675,000 | -100.0% | -2.74% | – |
SLXP | Exit | SALIX PHARMACEUTICALS INC | $0 | – | -525,000 | -100.0% | -3.36% | – |
KEYS | Exit | KEYSIGHT TECHNOLOGIES INC | $0 | – | -2,043,826 | -100.0% | -3.85% | – |
VRX | Exit | VALEANT PHARMACEUTICALS INTL | $0 | – | -650,000 | -100.0% | -5.18% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
HUMANA INC | 22 | Q3 2022 | 6.6% |
BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
BIOGEN INC | 21 | Q3 2022 | 8.5% |
LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2023-05-26 |
4 | 2023-05-26 |
SC 13D/A | 2023-05-26 |
4 | 2023-04-04 |
4 | 2023-04-04 |
SC 13D/A | 2023-04-03 |
13F-HR | 2023-02-15 |
SC 13G/A | 2023-02-14 |
4 | 2023-01-04 |
4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.